SANA vs VALN
Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.
SANA · Sana Biotechnology$1.59 ▼ 8.62%
VALN · Valneva$5.16 ▼ 3.82%
One year, rebased to 100
Each line starts at 100 so growth is directly comparable
- SANA -55.1%
- VALN -41.5%
Head to head
| Metric | SANA | VALN |
|---|---|---|
| Price | $1.59 | $5.16 |
| Change today | ▼ 8.62% | ▼ 3.82% |
| Market cap | $476.42M | $490.86M |
| Return, 3 months | -57.9% | -23.6% |
| Return, year to date | -60.9% | -41.5% |
| Return, 1 year | -51.7% | -40.1% |
| P/E (TTM) | – | – |
| P/B | 2.6 | 5.5 |
| P/E percentile vs own 5y | 39th | 89th |
| Dividend yield | – | – |
| Revenue growth (YoY, latest qtr) | – | -27.7% |
| Net profit growth (YoY) | +148.4% | -169.3% |
| Gross margin | – | 16.4% |
| Operating margin | – | -80.4% |
| Net margin | – | -110.3% |
| Return on equity | -79.5% | -117.8% |
| Analyst target vs. price | +403.1% | +248.8% |
| Analyst buy share | 100% | 100% |
| RSI (14) | 24 | 37 |
| 30-day volatility | 83.1% | 48.5% |
| Max drawdown, 1 year | -69.3% | -60.1% |
| Trend read | Strong downtrend | Strong downtrend |
| Analyst consensus | Buy | Buy |
Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.
What the numbers say
- VALN is the largest of the group by market value.
- VALN has returned the most over the past year.
- VALN has been the calmest stock over the last 30 days.